Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M549Revenue $M10.5Net Margin (%)-270.5Altman Z-Score19.7
Enterprise Value $M486EPS $-0.6Operating Margin %-285.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-270.6Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %-16.8Quick Ratio10.7Cash flow > EarningsN
Price/Sales35.15-y EBITDA Growth Rate %-5.0Current Ratio10.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-30.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.8ROIC % (ttm)-235.3Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOFirst Eagle Investment 2014-03-31 Sold Out $9.76 - $15.28
($11.96)
$ 7.87-34%Sold Out0
INOFirst Eagle Investment 2013-12-31 Buy $6.92 - $11.88
($8.34)
$ 7.87-6%New holding62,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cabrera AngelDirector 2015-04-13Buy8,000$9.53-17.42 view
KIES PETERCFO 2014-10-09Buy3,960$10.1-22.08 view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.01-21.38 view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.74-19.2 view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.06-13.13 view
Sardesai NiranjanCOO 2014-08-12Buy2,550$8.7-9.54 view
Kim Jong JosephCEO 2014-04-15Buy6,250$9-12.56 view
COLLINS MORTONDirector 2013-11-13Buy63,625$7.288.1 view
Bagarazzi MarkChief Medical Officer 2013-04-16Buy15,000$2.24251.34 view
Kim Jong JosephCEO, 10% Owner 2013-04-02Buy22,500$2293.5 view

Press Releases about INO :

Quarterly/Annual Reports about INO:

News about INO:

Articles On GuruFocus.com
Inovio Pharmaceuticals' CEO Dr. J. Joseph Kim Interviewed by The Life Sciences Report Oct 30 2014 
Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
comment on INO May 10 2013 
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
Any opinions regarding Apr 12 2010 

More From Other Websites
Why no MERS vaccine? Lack of foresight frustrates scientists Jun 15 2015
3 Reasons Inovio Pharmaceuticals Stock Could Rise Jun 12 2015
Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" by Ernst & Young Jun 12 2015
Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" by Ernst & Young Jun 12 2015
Why Inovio Pharmaceuticals (INO) Could Be Positioned for a Surge? - Tale of the Tape Jun 10 2015
Video-Revolutionizing the Fight Against Cancers and Infectious Diseases for Inovio Pharmaceuticals,... Jun 09 2015
Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical... May 27 2015
Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical... May 27 2015
Inovio to Present at Jefferies Healthcare Conference May 26 2015
Inovio to Present at Jefferies Healthcare Conference May 26 2015
5 Things Inovio Pharmaceuticals Wants You to Know May 22 2015
INOVIO PHARMACEUTICALS, INC. Financials May 16 2015
Corporate Profile for Inovio Pharmaceuticals, Inc. May 16 2015
Video-Corporate Presentation - May 2015 for Inovio Pharmaceuticals, Inc. May 15 2015
Inovio Earnings: 3 Key Takeaways You Missed May 12 2015
INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 12 2015
Inovio Narrows Q1 Loss Y/Y, Misses Earnings Estimates - Analyst Blog May 12 2015
Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola May 12 2015
Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola May 12 2015
Inovio Pharmaceuticals Reports 2015 First Quarter Financial Results May 11 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK